ACON

ACON

Aclarion Inc

Net -3.44%top 1%Rev 65.62%top 1%Revenue grew 100% of years1Y
Hold

Aclarion, Inc. develops healthcare technology using magnetic resonance spectroscopy to analyze intervertebral discs, optimize pain treatment, and provide biomarker data for chronic low back pain, enhancing traditional MRI diagnostics with custom software solutions.

โš•๏ธ Healthcare NASDAQ Listed 2022 $ USD
$1,000 invested 1 year ago โ†’$319today

Score Overview

1 Year
Scoreโ€”
Net Growth-3.44%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth65.62%
Rev TrendGrew
Revenue Consistencyโ€”
All Time
Scoreโ€”
Net Growth-2.33%
Net Trend33%
Net Income Consistencyโ€”
Rev Growth25.29%
Rev Trend67%
Revenue Consistencyโ€”

See the full market ranking โ†’

Aclarion Inc fundamental performance

Across Aclarion Inc's full reported history, from 2022 to 2025, revenue grew from $ 60.44K to $ 75.73K and net income went from -$ 7M to -$ 7M. Revenue increased in 67% of the years measured; net income in 33%.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 2.32โ€”
1 Year2025-08-12
$ 7.28-68.13%
All Time2022-04-22
$ 393.64K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2025$ 75.73K-$ 7M$ 12.01T
2024$ 45.72K-$ 6M$ 453.66K
2023$ 75.4K-$ 4M$ 1M
IPO2022$ 60.44K-$ 7M$ 1M

Explore beyond ACON

You're looking at Aclarion Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies